Elanix Biotechnologies

About:

Elanix Biotechnologies is a life sciences company that specializes in tissue regeneration products.

Website: https://elanixbiotechnologies.com

Description:

Elanix Biotechnologies is a tissue regeneration company. We develop and commercialize products for acute wound care, dermatological and gynecological applications, as well as providing cell technology services. The company was founded in 2013 as a spin-out from the University Hospital of Lausanne (CHUV), Switzerland, to commercialize a patented progenitor cell technology. Progenitor cells are fully differentiated yet immunologically neutral cells that are very potent inducers of tissue growth and healing. Elanix owns GMP certified Master and Working cell banks containing vast quantities of cells. The Company is headquartered in Nyon, Switzerland with offices in Wiesbaden and listed on the Frankfurt stock exchange under the symbol ELN.

Total Funding Amount:

4M EUR

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Berlin, Berlin, Germany

Founded Date:

1994-01-01

Contact Email:

info(AT)elanix.ch

Founders:

Lee Ann Laurent- Applegate

Number of Employees:

11-50

Last Funding Date:

2018-04-30

IPO Status:

Public

Industries:

© 2025 bioDAO.ai